In this podcast we feature an article about what and who is behind Viatris, the new company formed from the combination of Upjohn, Pfizer’s off-patent branded and generic established medicines business, and Mylan. For the text version of this article visit dcatvci.org.

Key topics: (see Chapter Markers)

• Rationale for the new company
• Inside the new Viatris: products
• Inside the new Viatris: manufacturing
• Inside Viatris: leadership, company structure, and cost-savings plan

Sponsor: LabVantage Solutions